Biofrontera Aktie
| 2,63EUR | 0,00EUR | 0,00% |
WKN DE: A4BGGM / ISIN: DE000A4BGGM7
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 149 | 99 | 110 | 95 | 88 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,20 | 0,29 | 0,23 | 0,34 | 0,25 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 26 | 14 | 15 | 18 | 16 |
| Summe Anlagevermögen | 32 | 63 | 18 | 14 | 14 |
| Summe Aktiva | 58 | 77 | 33 | 31 | 30 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 51 | 19 | 13 | 11 | 11 |
| Summe Eigenkapital | 7 | 58 | 20 | 20 | 19 |
| Summe Passiva | 58 | 77 | 33 | 31 | 30 |
Adresse
| Hemmelrather Weg 201, 51377 Leverkusen | |
| Telefon | +49 (214) 87-63-2-0 |
| Fax | +49 (214) 87-63-2-90 |
| Internet | http://biofrontera.com |
Management
|
Alexander Link
Chairman-Supervisory Board |
|
Hansjörg Plaggemars
Member-Supervisory Board |
|
Heikki Lanckriet
Member-Supervisory Board |
|
Helge Lubenow
Deputy Chairman-Supervisory Board |
|
Karlheinz Schmelig
Member-Supervisory Board |
|
María del Pilar de la Huerta Martínez
Chief Financial Officer |
|
Tobias Reich
Member-Supervisory Board |